We summarise the key changes to the ICMJE recommendations for authors and medical publication professionals.
Abstract ‘spin’ can distort a study’s findings and lead to inappropriate conclusions being drawn. But just how prevalent is this problem?
[VIDEO] Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
[VIDEO] Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review
Obaro Evuarherhe, Principal Consultant at Oxford PharmaGenesis, discusses professional medical writing support and the quality, ethics and timeliness of clinical trial reporting.
A new tool from MPIP provides easily accessible information on open access options for industry-funded research.
Does professional medical writing support impact the quality, ethics and timeliness of clinical trial reporting?
Findings of a systematic review show working with professional medical writers positively affects measures of quality, ethics and timeliness.
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
Join CBI for the latest updates on data sharing, collaborating with patients and innovations in publishing.
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.
A recent article from The Chronicle of Higher Education discusses the potential benefits associated with journals that are established by funding bodies.
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
Are you familiar with the FAIR data principles? Find out how to boost your data’s usefulness by making your data FAIR: Findable, Accessible, Interoperable, and Reusable.
Authors and editors are asked to be vigilant, and advice to peer reviewers is updated, amidst scandal of reviewer who asked for multiple self-citations during reviews.
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
A recent blog for The Scholarly Kitchen suggests mergers, acquisitions, and new regulations are increasingly changing the state of scholarly communications.
As an increasing number of journals pilot transparent peer review, data indicate that open peer review does not compromise the process – at least when reviewers can stay anonymous.